Patent · US Active

Organic compounds

US10203327B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignees

Novartis AG · CH
Odega S.A. · BE

Inventors

Frederic Bassilana · Basel, CH
Birgit Baumgarten · Riehen, CH
Nathalie Marie-Therese Carte · Huningue, FR
Michel Detheux · Mignault, BE
Rocco Falchetto · Bellinzona, CH
Sebastien Hannedouche · Belefanai, LR
Vincent Lannoy · Liernu, BE
Keith Mansfield · Shrewsbury, US
Klaus Seuwen · Michelbach-le-Bas, FR
Thomas Laurent Henri Suply · Zimmersheim, FR

Key dates

Filing date	Oct 23, 2014
Grant date	Feb 12, 2019
Priority date	—
Expiry date	Feb 25, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/4719
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to modulators of the interaction between G-protein coupled receptor 15(GPR15) and c10orf99. The modulator may be a small chemical molecule, antibody or other therapeutic protein. Methods of medical treatment and methods of identifying modulators are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.